FDA advisory committee

AZ
Biotech

FDA panel rejects AstraZeneca's novel oral SERD proposal

By a vote of 6-to-3, an FDA expert panel shot down AstraZeneca's novel proposal of using its oral SERD camizestrant as a first-line switch therapy.
Angus Liu Apr 30, 2026 1:48pm
FDA

FDA flags concerns for AZ's camizestrant, Truqap ahead of adcomm

Apr 28, 2026 2:47pm
An artists concept of chains of amino acides called peptides which together make up polypeptides or proteins
Favicon Fierce Pharma

FDA advisory committee to discuss action on unapproved peptides

Apr 15, 2026 5:15pm
FDA conference hall

FDA to end 9-month adcomm hiatus with review of AZ cancer drugs

Mar 6, 2026 11:16am
Duchenne muscular dystrophy DMD

Capricor shares turn red as FDA announces deramiocel adcomm plan

May 6, 2025 8:32am
FDA Adcomm

After agony, FDA adcomm favors Stealth's ultra-rare disease drug

Oct 10, 2024 6:20pm